(19)

(11)

EP 3 928 328 A1

(12)

(43) Date of publication: 29.12.2021 Bulletin 2021/52 (21) Application number: 20758656.1 (22) Date of filing: 21.02.2020

(51) International Patent Classification (IPC):  G16H 50/20(2018.01) G16H 10/60(2018.01) G16H 80/00(2018.01) G16H 50/30(2018.01) G16H 20/10(2018.01) (52) Cooperative Patent Classification (CPC): G16H 40/63; G16H 20/17; A61K 38/225; G16H 20/13; G16H 50/20; A61B 5/1118; A61B 5/7275; A61B 2562/0219; G16H 40/67; A61B 5/021; A61B 5/0004; A61B 5/024 (86) International application number: PCT/US2020/019202 (87) International publication number: WO 2020/172520 (27.08.2020 Gazette 2020/35)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 22.02.2019 US 201962809251 P (71) Applicant: Pear Therapeutics, Inc. Boston, MA 02109 (US)	(72) Inventors: MANTEAU-RAO, Marguerite Boston, MA 02109 (US) NABHAN, Antoun Boston, MA 02109 (US) (74) Representative: J A Kemp LLP  80 Turnmill Street London EC1M 5QU London EC1M 5QU (GB)